Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Paolo Sfriso et al.|Frontiers in Pharmacology|2019Cited by 616
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Luca Cantarini, Antonella Insalaco et al.|Frontiers in Pharmacology|2016Cited by 88
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Jurgen Sota, Antonio Vitale et al.|Clinical Rheumatology|2018Cited by 82
A national cohort study on pediatric Behçet’s disease: cross-sectional data from an Italian registryRomina Gallizzi, Rolando Cimaz, Caterina Pidone et al.|Pediatric Rheumatology|2017Cited by 77
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritisJessica Tibaldi, Nicolino Ruperto, Angela Pistorio et al.|Lara D. Veeken|2020Cited by 66